Abstract

Aim

The objective is to assess electrocardiographic characteristics predicting the precise location of ventricular arrhythmia (VA) origin within the right ventricle (RV) close to the His bundle (HB) region.

Methods and results

Twenty-five patients (14 men, age 65 ± 14 years) underwent successful catheter ablation of para-Hisian VA. Ventricular arrhythmias were considered to arise in the vicinity of the HB region based on the criteria that mapping exhibited the earliest RV activation before QRS onset in the HB region. Surface 12-lead electrocardiogram during the para-Hisian VAs was analysed. Of the 25 patients, 8 originated from the RV antero-septum just above the HB region, and 17 arose from the RV mid-septum just below the HB region. There was no significant difference in precedence of the local ventricular electrogram of the HB region from the onset of surface QRS during VAs. Surface electrocardiographic findings were characterized according to R-wave amplitude in lead I (0.43 ± 0.18 vs. 0.67 ± 0.19 mV, P = 0.005), mean R-wave amplitude in inferior leads (1.12 ± 0.32 vs. 0.71 ± 0.24 mV, P = 0.002), R-wave amplitude ratio of leads III/II (0.77 ± 0.10 vs. 0.50 ± 0.23, P = 0.005), incidence of S-wave in lead III [1/8 (13%) vs. 16/17 (94%), P < 0.001], and QS morphology in lead V1 [3/8 (38%) vs. 17/17 (100%), P = 0.001].

Conclusions

Despite their adjacent locations, para-Hisian VAs could be classified into two subgroups with distinctive electrocardiographic characteristics according to origin either above or below the HB region. The present findings can be helpful for planning catheter ablation of para-Hisian VAs, and can reduce the risk of inadvertent atrioventricular block.

Introduction

Radiofrequency (RF) catheter ablation is widely accepted as a safe and reliable therapy of idiopathic ventricular arrhythmia (VA) originating from the ventricular outflow tract.1–6 It has been reported that idiopathic VAs can arise from the right ventricular (RV) septum in the vicinity of the His bundle (HB),7–15 and the incidence of para-Hisian VA is not neglegible.7,8 Radiofrequency catheter ablation of the para-Hisian VAs has the potential risk of inadvertent damage to the atrioventricular conduction system. As previously described, knowledge of electrocardiographic characteristics of para-Hisian VAs can be helpful for differentiation from VAs originating from the RV outflow tract.8 However, little is known about detailed characteristics of electrocardiographic morphology that can predict the precise localization of VA origin within para-Hisian areas. The present study was undertaken to clarify these points.

Methods

Study population

This retrospective study included 262 consecutive patients (128 men and 134 women, mean age 57 ± 16 years old) who underwent successful endocardial RF ablation of idiopathic VAs with a left bundle branch block morphology and inferior-axis deviation. No structural heart disease was apparent by physical examination, echocardiography, or coronary angiography. At least once before the ablation procedure, 24-h ambulatory Holter monitoring was performed. All antiarrhythmic drugs (AADs) except for amiodarone were discontinued for at least five half-lives before the procedure. Amiodarone was stopped at least 1 month before the procedure. All patients gave their written informed consent prior to the procedure.

Electrophysiological study

Two 5-French quadripolar catheter were introduced from the right femoral vein and placed at the RV apex and HB region, respectively. If few VAs were observed at the beginning of the procedure, burst pacing from the RV apex was performed with addition of intravenous isoproterenol (0.5–3.0 µg/min) infusion to provoke the clinical arrhythmia. A systematic anticoagulation with heparin was maintained during the procedure. The surface 12-lead electrocardiogram (ECG) and intracardiac electrograms were continuously monitored at a speed of 100 mm/s and stored on a computer-based digital amplifier (Labsystem Pro, Bard Electrophysiology, MA, USA).

Mapping and radiofrequency catheter ablation

Mapping and ablation were performed using a 7-French 4 mm tip non-irrigated catheter (Fantasista, Japan Lifeline, Tokyo, Japan) introduced from the right femoral vein for the RV or from the right femoral artery for the aortic sinus cusps. The origin of clinical VA was searched by activation and pace mapping. If the ventricular activation from the HB region were the earliest of the entire RV mapping site, we mapped the aortic sinus cusps. Pace mapping was performed at a pacing cycle length of 500 ms at a current just greater than diastolic threshold by using the distal bipolar electrodes. Radiofrequency energy was applied at the site where the earliest ventricular activation was recorded or where a matching pace map was obtained. A matching pace map was defined as a pace map that matched the QRS complex of a target VA in at least 10 of 12 leads. Radiofrequency energy was applied in a temperature-controlled manner at a temperature setting of 50–55°C and maximum power output of 50 W up to 120 s at the presumed ablation site. If any acceleration or reduction of the clinical VAs was not observed during the first 15 s of the RF application, the RF delivery was terminated and the catheter was repositioned. If the target VAs were affected within the first 15 s of RF application, RF delivery was continued. If the earliest ventricular activation and best pace mapping was observed at the RV septum in the vicinity of the HB region, RF energy was delivered starting with an initial power setting of 20 W by using a long sheath (SL0, St Jude Medical, St Paul, MN, USA) in order to assure the stability of the ablation catheter. If an accelerated junctional rhythm was present during RF energy delivery, the RF current was immediately discontinued. Thereafter, if no effect on the atrioventricular conduction system was confirmed, we re-started it during right atrial pacing at a rate slightly faster than the junctional beats. When a reduction in the para-Hisian VA was observed without any effect on the atrioventricular conduction system, the RF energy was gradually titrated up to the target output under continuous bilateral fluoroscopic guidance. If the site demonstrating the earliest activation during VA and perfect pace map was where an apparent HB potential of >0.1 mV was recorded, we forwent the elimination of the VA by ablation to avoid complete atrioventricular nodal block.

Definition of His bundle location for origin of ventricular arrhythmia

The HB region was determined as the site where the largest HB potential was recorded under the guidance of the right and left anterior oblique fluoroscopic views. The VA were considered to arise from the RV septum in the vicinity of the HB region based on the criteria that mapping exhibited the ventricular activation recorded in the RV septum close to the HB region preceded the onset of surface QRS during the VA. The anatomical relation between the effective ablation site of para-Hisian VA and the site recording the largest HB potential was assessed under the bilateral fluoroscopic guidance.

Electrocardiographic analysis

The analysis of surface 12-lead ECG during the clinical VA focused on the following characteristics: (i) the duration of the total QRS complex; (ii) the morphology of the QRS complex in leads I, II, III, aVR, aVL, aVF, and V1; (iii) the magnitude of the R-wave in leads II, III, and aVF; (iv) the R-wave amplitude ratio of lead II and III, which was calculated as a percentage by dividing the R-wave amplitude in lead III by that in lead II; and (v) the site of R-wave transition in the precordial leads. Capital letters (Q, R, and S) are used here to refer to waves of relatively high amplitude (>0.5 mV), and lowercase letters (q, r, and s) refer to waves of relatively low amplitude (<0.5 mV).

Follow-up

All AADs were discontinued after the procedure in all patients. After the ablation procedure, ECG monitoring was performed for 48 h in all patients. After hospital discharge, the patients underwent follow-up consisting of a clinical interview, 12-lead ECG, and 24 h Holter monitoring 1 month later and then every 3–6 months at our cardiology clinic. If the patients had any rhythm-related symptoms, a 12-lead ECG and 24 h Holter monitoring were recorded to document the cause of the symptoms. Successful ablation was defined as the following: the absence of spontaneous or induced clinical VAs during an isoproterenol infusion and burst RV pacing at the end of the procedure; the absence of these VAs after 48 h of continuous electrocardiographic monitoring after ablation without AADs; and no recurrence of the target VAs in the absence of AADs during follow-up.

Statistical analysis

Continuous values are expressed as mean ± standard deviation and were compared using unpaired Student's t-test. Categorical variables are reported as number and percentages, and were compared using Fisher's exact test. The sensitivity, specificity, and positive and negative predictive accuracies of the electrocardiographic variables were calculated for predicting the preferential location of para-Hisian VA origin within para-Hisian areas. The diagnostic accuracies of continuous electrocardiographic variables for predicting it were assessed using receiver-operating characteristic (ROC) curves and expressed by the area under the curve (AUC) with 95% confidence interval (CI). A cut-off value was determined tentatively as the point on the ROC curve closest to the upper left corner. A value of P < 0.05 was considered statistically significant.

Results

Among the total 262 patients, the successful ablation site was located at the RV outflow tract in 193, the RV septum close to the His-bundle region in 25, aortic cusp in 39, and the left ventricular outflow tract in 5 patients. We assessed the electrocardiographic and electrophysiological characteristics in the 25 patients (14 men, age 65 ± 14 years old) who underwent successful RF ablation of para-Hisian VA. All the 25 patients had a normal ECG during sinus rhythm, and no structural heart disease was apparent by physical examination, echocardiography, or coronary angiography. Mean left ventricular ejection fraction was 66.7 ± 6.2%. These 25 patients were classified into two subgroups according to location of the successful ablation site: Group-A (n = 8), RV antero-septum just above the site where the largest HB potential was recorded, and Group-B (n = 17), RV mid-septum just below the HB region (Figure 1).

Right anterior oblique and LAO radiographic views of the ablation catheter at the typical sites of successful ablation. (A) Ablation catheter at the right ventricular antero-septum just above the His bundle region. (B) Ablation catheter at the right ventricular mid-septum just below the His bundle region. ABL, ablation catheter; HB, His bundle; LAO, left anterior oblique; RAO, right anterior oblique; RV, right ventricle.
Figure 1

Right anterior oblique and LAO radiographic views of the ablation catheter at the typical sites of successful ablation. (A) Ablation catheter at the right ventricular antero-septum just above the His bundle region. (B) Ablation catheter at the right ventricular mid-septum just below the His bundle region. ABL, ablation catheter; HB, His bundle; LAO, left anterior oblique; RAO, right anterior oblique; RV, right ventricle.

Clinical and electrophysiologic findings

Monomorphic ventricular tachycardia, defined as three or more consecutive ventricular premature contractions, was present in 7 patients (Group-A: 3 and Group-B: 4), and the remaining 18 patients had monomorphic ventricular premature contractions (Group-A: 5 and Group-B: 13). Group-B patients was significantly older than Group-A patients (Group-A: 54 ± 18 years old vs. Group-B: 70 ± 9 years old, P = 0.027). There was no difference in gender. There was no significant difference in the number of ventricular ectopic beats per 24 h between the groups (Group-A: 13 967 ± 7018 vs. Group-B: 16 851 ± 9530, P = 0.45). No statistically significant difference was observed in the precedence of the local ventricular electrogram of the HB from the onset of the surface QRS during VAs (Group-A: 21.9 ± 4.2 ms vs. Group-B: 23.0 ± 4.3 ms, P = 0.54).

Ablation results of para-Hisian ventricular arrhythmia

During the procedure, the clinical arrhythmia was observed spontaneously in 23 patients, and induction of arrhythmias by burst pacing or an isoproterenol infusion was needed in 2 patients. In all the 25 patients, clinical VAs were successfully eliminated by ablation without any serious complications except for a transient right bundle branch block in 1 patient. During follow-up, all the 25 patients were free from arrhythmias without any AADs after a single ablation procedure.

There was no significant difference in the mean number of ablation attempts (Group-A: 3.6 ± 2.1 vs. Group-B: 3.3 ± 2.5, P = 0.75), the mean duration of the RF energy applications (Group-A: 3.3 ± 2.0 min vs. Group-B: 2.9 ± 1.8 min, P = 0.64). The precedence of the local ventricular activation of the ablation site was also similar between the groups (Group-A: 28.6 ± 4.3 ms vs. Group-B: 28.1 ± 4.4 ms, P = 0.77). The incidence of an HB potential of <0.1 mV at successful ablation site was higher in Group-B [5/17 (29%)] than in Group-A [1/8 (12%)]. Of important, an accelerated junctional rhythm was present during the RF application in 6 of 17 (35%) Group-B patients, whereas it was never observed in Group-A patients, suggesting the high risk of complication of atrioventricular conduction block during ablation on the RV mid-septum just below the HB region. In the Group-B, 15 of 17 (88%) patients had high-frequency potentials with fragmentation in the distal bipolar electrograms on the site demonstrating the earliest activation during VAs and excellent pace map (Figure 2), whereas in the Group-A, only 2 of 8 (25%) had fragmented potentials on the presumed ablation site and the remaining 6 had a single R-wave without any fragmentation.

Intracardiac recordings at the successful ablation site of ventricular arrhythmia originating from the right ventricular mid-septum just inferior to the His bundle (HB). During the ventricular arrhythmia, the earliest ventricular activation recorded from the distal bipolar signal of mapping catheter (MAP d) and HB region preceded the onset of the QRS complex by 28 and 20 ms, respectively. Of note, high-frequency potential with fragmentation (arrow) was observed in the bipolar electrogram of MAP d.
Figure 2

Intracardiac recordings at the successful ablation site of ventricular arrhythmia originating from the right ventricular mid-septum just inferior to the His bundle (HB). During the ventricular arrhythmia, the earliest ventricular activation recorded from the distal bipolar signal of mapping catheter (MAP d) and HB region preceded the onset of the QRS complex by 28 and 20 ms, respectively. Of note, high-frequency potential with fragmentation (arrow) was observed in the bipolar electrogram of MAP d.

Electrocardiographic findings

Representative 12-lead ECGs of para-Hisian VAs are shown in Figure 3. Electrocardiographic characteristics of these VAs are shown in Table 1, and the comparison of the characteristics between the groups was summarized in Table 2. In all patients, QRS complexes during VAs showed a left bundle branch block morphology and inferior-axis deviation. Precordial R-wave transition occurred between leads V2 and V3 in 4 of 8 (50%) Group-A patients and in 10 of 17 (59%) Group-B patients. There was no significant difference between groups in mean QRS duration in the inferior leads. A QS morphology in lead V1 was observed in three of eight (38%) Group-A patients, whereas all Group-B patients had a QS morphology in lead V1 (P = 0.001). A monophasic R- or r-wave in lead I was observed in all patients. A taller R-wave amplitude in lead I during para-Hisian VA than that during sinus rhythm was observed in 5 of 8 (63%) Group-A patients and in 14 of 17 (82%) Group-B patients (P = 0.34). An R-wave amplitude in lead I in Group-B was significantly higher than that in Group-A (Group-A: 0.43 ± 0.18 mV vs. Group-B: 0.67 ± 0.19 mV, P = 0.005). An R- or r-wave in lead aVL was observed in 6 of 8 (75%) Group-A patients and 16 of 17 (94%) Group-B patients (P = 0.23). An S- or s-wave in lead III was observed in 1 of 8 (13%) Group-A patients and in 16 of 17 (94%) Group-B patients (P < 0.001). Mean R-wave amplitude in the inferior leads in Group-B was significantly smaller than that in Group-A (Group-A: 1.12 ± 0.32 mV vs. Group-B: 0.71 ± 0.24 mV, P = 0.002). The R-wave amplitude ratio in leads II and III, which was calculated as a ratio by dividing the R-wave amplitude in lead III by that in lead II, was significantly greater in Group-A than in Group-B (Group-A: 0.77 ± 0.10 vs. 0.50 ± 0.23, P = 0.005). The optimal cut-off values and predictive accuracies of these electrocardiographic characteristics for VA of Group-B are summarized in Table 3. According to ROC curve analysis, the optimal cut-off value of R-wave amplitude in lead I, mean R-wave amplitude in the inferior leads, and R-wave amplitude ratio in leads II and III for predicting VA of Group-B was 0.45, 0.91, and 0.67 mV, respectively. ROC curve analysis represented that the AUC of R-wave amplitude in lead I, mean R-wave amplitude in the inferior leads, and R-wave amplitude ratio in leads II and III were calculated to be 0.842 (95% CI: 0.641–0.955, P < 0.001), 0.857 (95% CI: 0.659–0.962, P < 0.001), and 0.879 (95% CI: 0.686–0.973, P < 0.001), respectively.

Table 1

Clinical, electrophysiological, and electrocardiographic characteristics

QRS
PatientsAge (years)SexTypeIIIIIIIaVRaVLaVFV1TransitionDuration (ms)R amplitude (mV)III/II ratioV-QRS His (ms)
Group-A
158FNSVTrRRQSqrRrSV3–V41191.540.8630
276MVPCrRRQSqrRrSV2–V31241.440.8825
360MNSVTrRRQSrsRrSV3–V41270.960.7421
474FVPCRRRsQSrRsQSV2–V31210.60.5824
543FNSVTRRRQSrRrSV2–V31320.890.7017
623MVPCrRRQSqsRQSV3–V41281.140.8720
739FVPCrRRQSqsRQSV2–V31251.370.8019
857MVPCrRRQSrsRrSV3–V413610.7419
Group-B
174MNSVTRRrsQSRRQSV3–V41250.610.4326
262FVPCrRRQSqsRQSV2–V31330.900.8020
364MVPCRRsRsQSqRRsQSV2–V31200.970.6718
453FVPCRRsRSQSrsRRsQSV2–V31230.870.5930
564MVPCRRrsQSrRsQSV2–V31220.630.5124
668MNSVTRRsRSQSqRRsQSV2–V31190.900.5026
776MNSVTRRRSQSqrRQSV3–V41280.700.6620
862FVPCRRrSQSRRsQSV3–V41250.650.2822
971MVPCRRqrSQSRqrSQSV3–V41260.370.1624
1069MVPCrRRsQSqrRQSV3–V41200.780.6520
1167FVPCRRRsQSqRRsQSV2–V31340.910.7716
1284MVPCRRQSQSRQSQSV3–V41220.12018
1379MVPCRRRsQSrsrRsQSV2–V31210.880.7822
1485MVPCRRqrSQSRqrSQSV2–V31290.330.1720
1582FVPCrRRsQSqrRQSV2–V31190.890.528
1664FVPCRRsrSQSrsRRsQSV2–V31180.830.5329
1772FNSVTRRrsQSRRQSV3–V41240.730.5028
QRS
PatientsAge (years)SexTypeIIIIIIIaVRaVLaVFV1TransitionDuration (ms)R amplitude (mV)III/II ratioV-QRS His (ms)
Group-A
158FNSVTrRRQSqrRrSV3–V41191.540.8630
276MVPCrRRQSqrRrSV2–V31241.440.8825
360MNSVTrRRQSrsRrSV3–V41270.960.7421
474FVPCRRRsQSrRsQSV2–V31210.60.5824
543FNSVTRRRQSrRrSV2–V31320.890.7017
623MVPCrRRQSqsRQSV3–V41281.140.8720
739FVPCrRRQSqsRQSV2–V31251.370.8019
857MVPCrRRQSrsRrSV3–V413610.7419
Group-B
174MNSVTRRrsQSRRQSV3–V41250.610.4326
262FVPCrRRQSqsRQSV2–V31330.900.8020
364MVPCRRsRsQSqRRsQSV2–V31200.970.6718
453FVPCRRsRSQSrsRRsQSV2–V31230.870.5930
564MVPCRRrsQSrRsQSV2–V31220.630.5124
668MNSVTRRsRSQSqRRsQSV2–V31190.900.5026
776MNSVTRRRSQSqrRQSV3–V41280.700.6620
862FVPCRRrSQSRRsQSV3–V41250.650.2822
971MVPCRRqrSQSRqrSQSV3–V41260.370.1624
1069MVPCrRRsQSqrRQSV3–V41200.780.6520
1167FVPCRRRsQSqRRsQSV2–V31340.910.7716
1284MVPCRRQSQSRQSQSV3–V41220.12018
1379MVPCRRRsQSrsrRsQSV2–V31210.880.7822
1485MVPCRRqrSQSRqrSQSV2–V31290.330.1720
1582FVPCrRRsQSqrRQSV2–V31190.890.528
1664FVPCRRsrSQSrsRRsQSV2–V31180.830.5329
1772FNSVTRRrsQSRRQSV3–V41240.730.5028

F, female; III/II ratio, the R-wave amplitude ratio in leads II and III; M, male; NSVT, non-sustained ventricular tachycardia; VPC, ventricular premature contraction; V-QRS His, the local ventricular activation time on the His bundle region relative to the surface QRS onset.

Table 1

Clinical, electrophysiological, and electrocardiographic characteristics

QRS
PatientsAge (years)SexTypeIIIIIIIaVRaVLaVFV1TransitionDuration (ms)R amplitude (mV)III/II ratioV-QRS His (ms)
Group-A
158FNSVTrRRQSqrRrSV3–V41191.540.8630
276MVPCrRRQSqrRrSV2–V31241.440.8825
360MNSVTrRRQSrsRrSV3–V41270.960.7421
474FVPCRRRsQSrRsQSV2–V31210.60.5824
543FNSVTRRRQSrRrSV2–V31320.890.7017
623MVPCrRRQSqsRQSV3–V41281.140.8720
739FVPCrRRQSqsRQSV2–V31251.370.8019
857MVPCrRRQSrsRrSV3–V413610.7419
Group-B
174MNSVTRRrsQSRRQSV3–V41250.610.4326
262FVPCrRRQSqsRQSV2–V31330.900.8020
364MVPCRRsRsQSqRRsQSV2–V31200.970.6718
453FVPCRRsRSQSrsRRsQSV2–V31230.870.5930
564MVPCRRrsQSrRsQSV2–V31220.630.5124
668MNSVTRRsRSQSqRRsQSV2–V31190.900.5026
776MNSVTRRRSQSqrRQSV3–V41280.700.6620
862FVPCRRrSQSRRsQSV3–V41250.650.2822
971MVPCRRqrSQSRqrSQSV3–V41260.370.1624
1069MVPCrRRsQSqrRQSV3–V41200.780.6520
1167FVPCRRRsQSqRRsQSV2–V31340.910.7716
1284MVPCRRQSQSRQSQSV3–V41220.12018
1379MVPCRRRsQSrsrRsQSV2–V31210.880.7822
1485MVPCRRqrSQSRqrSQSV2–V31290.330.1720
1582FVPCrRRsQSqrRQSV2–V31190.890.528
1664FVPCRRsrSQSrsRRsQSV2–V31180.830.5329
1772FNSVTRRrsQSRRQSV3–V41240.730.5028
QRS
PatientsAge (years)SexTypeIIIIIIIaVRaVLaVFV1TransitionDuration (ms)R amplitude (mV)III/II ratioV-QRS His (ms)
Group-A
158FNSVTrRRQSqrRrSV3–V41191.540.8630
276MVPCrRRQSqrRrSV2–V31241.440.8825
360MNSVTrRRQSrsRrSV3–V41270.960.7421
474FVPCRRRsQSrRsQSV2–V31210.60.5824
543FNSVTRRRQSrRrSV2–V31320.890.7017
623MVPCrRRQSqsRQSV3–V41281.140.8720
739FVPCrRRQSqsRQSV2–V31251.370.8019
857MVPCrRRQSrsRrSV3–V413610.7419
Group-B
174MNSVTRRrsQSRRQSV3–V41250.610.4326
262FVPCrRRQSqsRQSV2–V31330.900.8020
364MVPCRRsRsQSqRRsQSV2–V31200.970.6718
453FVPCRRsRSQSrsRRsQSV2–V31230.870.5930
564MVPCRRrsQSrRsQSV2–V31220.630.5124
668MNSVTRRsRSQSqRRsQSV2–V31190.900.5026
776MNSVTRRRSQSqrRQSV3–V41280.700.6620
862FVPCRRrSQSRRsQSV3–V41250.650.2822
971MVPCRRqrSQSRqrSQSV3–V41260.370.1624
1069MVPCrRRsQSqrRQSV3–V41200.780.6520
1167FVPCRRRsQSqRRsQSV2–V31340.910.7716
1284MVPCRRQSQSRQSQSV3–V41220.12018
1379MVPCRRRsQSrsrRsQSV2–V31210.880.7822
1485MVPCRRqrSQSRqrSQSV2–V31290.330.1720
1582FVPCrRRsQSqrRQSV2–V31190.890.528
1664FVPCRRsrSQSrsRRsQSV2–V31180.830.5329
1772FNSVTRRrsQSRRQSV3–V41240.730.5028

F, female; III/II ratio, the R-wave amplitude ratio in leads II and III; M, male; NSVT, non-sustained ventricular tachycardia; VPC, ventricular premature contraction; V-QRS His, the local ventricular activation time on the His bundle region relative to the surface QRS onset.

Table 2

Comparison of the electrocardiographic characteristics

Group-A (n = 8)Group-B (n = 17)P
QRS duration (ms)127 ± 6124 ± 50.23
Precordial R-wave transition
 V2–V3410
 V3–V447
Mean R-wave amplitude in inferior leads (mV)1.12 ± 0.320.71 ± 0.240.002
Voltage ratio lead III/II0.77 ± 0.100.50 ± 0.230.005
R-wave amplitude in lead I >0.5 mV2/8 (25%)14/17 (82%)0.010
R-wave amplitude in lead I (mV)0.43 ± 0.180.67 ± 0.190.005
R-wave in lead aVL6/8 (75%)16/17 (94%)0.23
S-wave in lead III1/8 (13%)16/17 (94%)<0.001
QS in lead V13/8 (38%)17/17 (100%)0.001
Group-A (n = 8)Group-B (n = 17)P
QRS duration (ms)127 ± 6124 ± 50.23
Precordial R-wave transition
 V2–V3410
 V3–V447
Mean R-wave amplitude in inferior leads (mV)1.12 ± 0.320.71 ± 0.240.002
Voltage ratio lead III/II0.77 ± 0.100.50 ± 0.230.005
R-wave amplitude in lead I >0.5 mV2/8 (25%)14/17 (82%)0.010
R-wave amplitude in lead I (mV)0.43 ± 0.180.67 ± 0.190.005
R-wave in lead aVL6/8 (75%)16/17 (94%)0.23
S-wave in lead III1/8 (13%)16/17 (94%)<0.001
QS in lead V13/8 (38%)17/17 (100%)0.001
Table 2

Comparison of the electrocardiographic characteristics

Group-A (n = 8)Group-B (n = 17)P
QRS duration (ms)127 ± 6124 ± 50.23
Precordial R-wave transition
 V2–V3410
 V3–V447
Mean R-wave amplitude in inferior leads (mV)1.12 ± 0.320.71 ± 0.240.002
Voltage ratio lead III/II0.77 ± 0.100.50 ± 0.230.005
R-wave amplitude in lead I >0.5 mV2/8 (25%)14/17 (82%)0.010
R-wave amplitude in lead I (mV)0.43 ± 0.180.67 ± 0.190.005
R-wave in lead aVL6/8 (75%)16/17 (94%)0.23
S-wave in lead III1/8 (13%)16/17 (94%)<0.001
QS in lead V13/8 (38%)17/17 (100%)0.001
Group-A (n = 8)Group-B (n = 17)P
QRS duration (ms)127 ± 6124 ± 50.23
Precordial R-wave transition
 V2–V3410
 V3–V447
Mean R-wave amplitude in inferior leads (mV)1.12 ± 0.320.71 ± 0.240.002
Voltage ratio lead III/II0.77 ± 0.100.50 ± 0.230.005
R-wave amplitude in lead I >0.5 mV2/8 (25%)14/17 (82%)0.010
R-wave amplitude in lead I (mV)0.43 ± 0.180.67 ± 0.190.005
R-wave in lead aVL6/8 (75%)16/17 (94%)0.23
S-wave in lead III1/8 (13%)16/17 (94%)<0.001
QS in lead V13/8 (38%)17/17 (100%)0.001
Table 3

Sensitivity, specificity, and positive and negative predictive accuracies for predicting para-Hisian ventricular arrhythmia arising from the right ventricular mid-septum just below the His bundle region

Sensitivity (%)Specificity (%)Positive predictive value (%)Negative predictive value (%)
R-wave amplitude in lead I > 0.45 mV82758867
R-wave amplitude in inferior leads <0.91 mV94758986
Voltage ratio lead III/II < 0.6782889370
QS morphology in V11006385100
S-wave in lead III94889488
Sensitivity (%)Specificity (%)Positive predictive value (%)Negative predictive value (%)
R-wave amplitude in lead I > 0.45 mV82758867
R-wave amplitude in inferior leads <0.91 mV94758986
Voltage ratio lead III/II < 0.6782889370
QS morphology in V11006385100
S-wave in lead III94889488
Table 3

Sensitivity, specificity, and positive and negative predictive accuracies for predicting para-Hisian ventricular arrhythmia arising from the right ventricular mid-septum just below the His bundle region

Sensitivity (%)Specificity (%)Positive predictive value (%)Negative predictive value (%)
R-wave amplitude in lead I > 0.45 mV82758867
R-wave amplitude in inferior leads <0.91 mV94758986
Voltage ratio lead III/II < 0.6782889370
QS morphology in V11006385100
S-wave in lead III94889488
Sensitivity (%)Specificity (%)Positive predictive value (%)Negative predictive value (%)
R-wave amplitude in lead I > 0.45 mV82758867
R-wave amplitude in inferior leads <0.91 mV94758986
Voltage ratio lead III/II < 0.6782889370
QS morphology in V11006385100
S-wave in lead III94889488
Representative 12-lead electrocardiograms of para-Hisian ventricular arrhythmiass. Ventricular arrhythmia originating from the right ventricular antero-septum above the His bundle region (Group-A). Ventricular arrhythmia originating from the right ventricular mid-septum below the His bundle region (Group-B).
Figure 3

Representative 12-lead electrocardiograms of para-Hisian ventricular arrhythmiass. Ventricular arrhythmia originating from the right ventricular antero-septum above the His bundle region (Group-A). Ventricular arrhythmia originating from the right ventricular mid-septum below the His bundle region (Group-B).

Discussion

Electrocardiographic findings of para-Hisian ventricular arrhythmia and proposed mechanism

Prior study has reported the electrocardiographic characteristics of para-Hisian VA as the following: the monophasic R-wave in lead I, QS pattern in lead V1, relatively narrow QRS duration, relatively low R-wave amplitude in inferior leads, lower R-wave amplitude in lead III than in lead II, and an early precordial tranditional zone in lead V2–V3.8 Although these electrocardiographic characteristics of para-Hisian VAs were helpful for differentiation from the RV outflow tract, the electrocardiographic characteristics predicting the precise localization of VA origin within para-Hisian areas have not been studied. We found that despite their adjacent locations and no significant difference in the precedence of the local ventricular electrogram of the HB from the surface QRS onset during para-Hisian VAs, para-Hisian VAs were divided into two subgroups according to the anatomic site of origin, either above or below the site recording the largest HB potential. There were significant differences in the electrocardiographic characteristics between the groups. Of our findings in this study subjects, the electrocardiographic characteristics of the para-Hisian VA arising from the RV mid-septum just below the HB region are more consistent with the findings of the prior report.8 We found that an R-wave amplitude in lead I of >0.45 mV, a mean R-wave amplitude in the inferior leads of <0.91 mV, an R-wave amplitude ratio of lead III/II of <0.67, an S-wave in lead III, and a QS morphology in lead V1 have been developed to predict the site of para-Hisian VAs originating from the RV mid-septum just below the HB region. These electrocardiographic characteristics suggest that the breakthrough site of them have more posterior and rightward anatomic location than that of para-Hisian VAs arising from the RV antero-septum above the HB region.

Of note, we found that para-Hisian VAs arising from the RV mid-septum were mainly observed in elderly patients. The anatomy of the summit of the ventricular septum in the vicinity of the HB region and its structures are complex. Previous histopathologic study described that the summit of the ventricular septum close to the HB region in elderly patients tends to undergo mechanical stress derived from the friction between the sclerotic circular fibrous annulus and the ventricular septum.16 Another prior study has also shown that senile degeneration of collagenous tissue occasionally composes the central fibrous body and the interventricular component of the membranous septum.17 Although in the present study, the detailed histopathology of the para-Hisian VAs remains to be investigated, there seems to be the possibility of the relation between the senile degenerative changes in the tissue of RV mid-septum near the HB region and the mechanisms underlying this arrhythmias. In addition, we found that the local bipolar electrograms at the successful ablation site of the para-Hisian RV mid-septum VAs revealed high-frequency and fragmented potentials, as we reported recently.11 Whereas the signals recorded on a healthy tissue represent a high-amplitude single potential, fractionated signals are thought to result from non-uniform anistropic conduction through areas of myocardium where conduction is slowed down and interrupted by fibrosis.18–21 As the precise mechanisms cannot be clearly clarified with the present clinical methods, our findings can be speculatively explained by the hypothesis that the local ventricular electrogram at the successful ablation site might be derived from the local electrical activity arising from an underlying pathological tissue in the para-Hisian RV mid-septum. Interestingly, these characteristics of local electrograms were not common in the para-Hisian RV antero-septum VAs. These two forms of para-Hisian VAs might have not only different electrocardiographic characteristics but also different electrophysiological properties in regard to the causation of the arrhythmias. Further electrophysiological and histopathological studies are required to explore the precise mechanisms underlying para-Hisian VAs.

Clinical implications

When ablating the para-Hisian VA, the following technical practice can minimize procedural complications: (i) use of a long guiding sheath to assure the stability of the ablation catheter; (ii) use of cryoablation;22,23 (ii) mapping from both the right and left side;9 and (iv) knowledge of local electrogram characteristics at the successful ablation site.11 In addition to these techniques, the electrocardiographic findings of this study can be helpful for avoiding an ineffective ablation of para-Hisian VA. Radiofrequency energy application at the RV mid-septum just below the HB region carries a particularly high risk of inadvertent atrioventricular conduction block because of the very close anatomic relation of its location to the atrioventricular node. Furthermore, an accelerated junctional rhythm during ablation on the RV mid-septum was occasionally observed, whereas it did not occur during ablation on the RV antero-septum just above the HB region. This finding also underscores the high risk of complication of atrioventricular conduction block during ablation on the RV mid-septum just below the HB region. The present electrocardiographic findings can be helpful information to estimate the preferential localization of the origin of para-Hisian VA within the RV septum para-Hisian areas, leading to reduce the risk of inadvertent damage to the atrioventricular conduction system.

Study limitations

This study was a retrospective analysis of a small population of patients with para-Hisian VAs. At first, the differences in voltage between various leads should be ensured in a larger population, whereas the QS pattern in V1 and S-wave in lead III is reasonable to apply in clinical practice. Secondly, we determined the ablation site under fluoroscopic guidance, and did not use any of three-dimensional electroanatomical tools or intracardiac echocardiography. As the His-bundle signal was continuously confirmed during the mapping and ablation by using the quadripolar catheter, there was no doubt regarding whether the locations on the RV septum where we ablated was above or below the site recording the largest HB potential under continuous bilateral fluoroscopic guidance. However, the use of three-dimensional electroanatomical tools or intracardiac echocardiography might be helpful for assessing more precise anatomical relation between the ablation site and structure in the HB region. Further prospective studies in a larger study population are needed to ensure the accuracy of our findings and to evaluate more precise anatomical localization of mapping catheter within the para-Hisian region.

Two para-Hisian VAs failed to be ablated because of transient atrioventricular block during the ablation. In two patients, the sites demonstrating the earliest activation during VA and perfect pace map were RV mid-septum just inferior to the HB. One of them was successfully eliminated at the right coronary cusp. In this study, we excluded these patients, because the aim of the present study was to assess the electrocardiographic characteristics predicting the preferential location of VA origin within the RV septum near the HB region. As previously described, it should be emphasized that when the ventricular activation in the RV HB region preceded the QRS onset during VA, mapping from both the right side and left side should be performed to attenuate the risk of inadvertent atrioventricular block.9

Conclusions

Despite their adjacent locations, para-Hisian VAs could be classified into two subgroups with distinctive electrocardiographic characteristics according to site of origin, either above or below the HB region. The present electrocardiographic findings allows us to identify the preferential localization of VA origin within para-Hisian areas, and can be helpful for planning catheter ablation of para-Hisian VAs and minimizing the risk of inadvertent atrioventricular block.

Conflict of interest: none declared.

References

1
Morady
F
Kadish
AH
DiCarlo
L
Kou
WH
Winston
S
deBuitlier
M
et al.
,
Long-term results of catheter ablation of idiopathic right ventricular tachycardia
Circulation
,
1990
, vol.
82
(pg.
2093
-
9
)
2
Klein
LS
Shih
HT
Hackett
FK
Zipes
DP
Miles
WM
,
Radiofrequency catheter ablation of ventricular tachycardia in patients without structural heart disease
Circulation
,
1992
, vol.
85
(pg.
1666
-
74
)
3
Coggins
DL
Lee
RJ
Sweeney
J
Chein
WW
Hare
GV
Epstein
L
et al.
,
Radiofrequency catheter ablation as a cure for idiopathic tachycardia of both left and right ventricular origin
J Am Coll Cardiol
,
1994
, vol.
23
(pg.
1333
-
41
)
4
Ouyang
F
Fotuhi
P
Ho
SY
Hebe
J
Volkmer
M
Goya
M
et al.
,
Repetitive monomorphic ventricular tachycardia originating from the aortic sinus cusp: electrocardiographic characterization for guiding catheter ablation
J Am Coll Cardiol
,
2002
, vol.
39
(pg.
500
-
8
)
5
Cole
CR
Marrouche
NF
Natale
A
,
Evaluation and management of ventricular outflow tract tachycardias
Card Electrophysiol Rev
,
2002
, vol.
6
(pg.
442
-
7
)
6
Miller
JM
Pezeshkian
NG
Yadav
AV
,
Catheter mapping and ablation of right ventricular outflow tract ventricular tachycardia
J Cardiovasc Electrophysiol
,
2006
, vol.
17
(pg.
800
-
2
)
7
Ito
S
Tada
H
Naito
S
Kurosaki
K
Ueda
M
Hoshizaki
H
et al.
,
Development and validation of an ECG algorithm for identifying the optimal ablation site for idiopathic ventricular outflow tract tachycardia
J Cardiovasc Electrophysiol
,
2003
, vol.
14
(pg.
1280
-
6
)
8
Yamauchi
Y
Aonuma
K
Takahashi
A
Sekiguchi
Y
Hachiya
H
Yokoyama
Y
et al.
,
Electrocardiographic characteristics of repetitive monomorphic right ventricular tachycardia originating near the His-bundle
J Cardiovasc Electrophysiol
,
2005
, vol.
16
(pg.
1041
-
8
)
9
Yamada
T
McElderry
HT
Doppalapudi
H
Kay
GN
,
Catheter ablation of ventricular arrhythmias originating from the vicinity of the His bundle: significance of mapping of the aortic sinus cusp
Heart Rhythm
,
2008
, vol.
5
(pg.
184
-
92
)
10
Shimoike
E
Ohba
Y
Yanagi
N
Ohtsuka
S
Ohnishi
Y
Ueda
N
et al.
,
Radiofrequency catheter ablation of idiopathic right ventricular tachycardia near the His bundle
Fukuoka Igaku Zasshi
,
1999
, vol.
90
(pg.
132
-
9
)
11
Komatsu
Y
Otomo
K
Taniguchi
H
Kakita
K
Takayama
K
Fujiwara
H
et al.
,
Catheter ablation of ventricular arrhythmias arising from the right ventricular septum close to the his bundle: features of the local electrogram at the optimal ablation site
J Cardiovasc Electrophysiol
,
2011
, vol.
22
(pg.
878
-
85
)
12
Kanagaratnam
L
Tomassoni
G
Schweikert
R
Pavia
S
Bash
D
Beheiry
S
et al.
,
Ventricular tachycardias arising from the aortic sinus of valsalva: an under-recognized variant of left outflow tract ventricular tachycardia
J Am Coll Cardiol
,
2001
, vol.
37
(pg.
1408
-
14
)
13
Callans
DJ
Menz
V
Schwartzman
D
Gottlieb
CD
Marchlinski
FE
,
Repetitive monomorphic tachycardia from the left ventricular outflow tract: electrocardiographic patterns consistent with a left ventricular site of origin
J Am Coll Cardiol
,
1997
, vol.
29
(pg.
1023
-
7
)
14
Tada
H
Tadokoro
K
Ito
S
Naito
S
Hashimoto
T
Kaseno
K
et al.
,
Idiopathic ventricular arrhythmias originating from the tricuspid annulus: prevalence, electrocardiographic characteristics, and results of radiofrequency catheter ablation
Heart Rhythm
,
2007
, vol.
4
(pg.
7
-
16
)
15
Zhu
DW
Maloney
JD
Simmons
TW
Nitta
J
Fitzgerald
DM
Trohman
RG
et al.
,
Radiofrequency catheter ablation for management of symptomatic ventricular ectopic activity
J Am Coll Cardiol
,
1995
, vol.
26
(pg.
843
-
9
)
16
Matsuyama
T
Inoue
S
Kobayasi
Y
Saito
T
Tanno
K
Sakai
T
et al.
,
Histopathologic exploration of intra-hisian conduction disturbances
J Cardiovasc Electrophysiol
,
2002
, vol.
13
(pg.
257
-
64
)
17
Allwork
SP
Anderson
RH
,
Developmental anatomy of the membranous part of the ventricular septum in the human heart
Br Heart J
,
1979
, vol.
41
(pg.
275
-
80
)
18
de Bakker
JM
van Capelle
FJ
Janse
MJ
van Hemel
NM
Hauer
RN
Defauw
JJ
et al.
,
Macroreentry in the infarcted human heart: the mechanism of ventricular tachycardias with a ‘focal’ activation pattern
J Am Coll Cardiol
,
1991
, vol.
18
(pg.
1005
-
14
)
19
Gardner
PI
Ursell
PC
Fenoglio
JJ
Jr
Wit
AL
,
Electrophysiologic and anatomic basis for fractionated electrograms recorded from healed myocardial infarcts
Circulation
,
1985
, vol.
72
(pg.
596
-
611
)
20
de Bakker
JM
van Capelle
FJ
Janse
MJ
Tasseron
S
Vermeulen
JT
de Jonge
N
et al.
,
Slow conduction in the infarcted human heart ‘Zigzag’ course of activation
Circulation
,
1993
, vol.
88
(pg.
915
-
26
)
21
de Bakker
JM
van Capelle
FJ
Janse
MJ
Tasseron
S
Vermeulen
JT
de Jonge
N
et al.
,
Fractionated electrograms in dilated cardiomyopathy: origin and relation to abnormal conduction
J Am Coll Cardiol
,
1996
, vol.
27
(pg.
1071
-
8
)
22
Atienza
F
Arenal
A
Torrecilla
EG
Garcia-Alberola
A
Jimenez
J
Ortiz
M
et al.
,
Acute and long-term outcome of transvenous cryoablation of midseptal and parahissian accessory pathways in patients at high risk of atrioventricular block during radiofrequency ablation
Am J Cardiol
,
2004
, vol.
93
(pg.
1302
-
30
)
23
Di Biase
L
Al-Ahamad
A
Santangeli
P
Hsia
HH
Sanchez
J
Bai
R
et al.
,
Safety and outcomes of cryoablation for ventricular tachyarrhythmias: results from a multicenter experience
Heart Rhythm
,
2011
, vol.
8
(pg.
968
-
74
)